{"id":47876,"date":"2020-07-31T04:00:40","date_gmt":"2020-07-31T09:00:40","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=topics&#038;p=47876"},"modified":"2020-08-14T09:35:34","modified_gmt":"2020-08-14T14:35:34","slug":"standardized-report-cards","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/","title":{"rendered":"Am\u00e9lioration des TRA : fiches de rendement normalis\u00e9es"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-47928 size-thumbnail\" src=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-150x150.png\" alt=\"ic\u00f4ne fiches de rendement normali\" width=\"150\" height=\"150\" srcset=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-150x150.png 150w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-300x300.png 300w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-250x250.png 250w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png.png 648w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>Les fiches de rendement normalis\u00e9es aident les radiologistes \u00e0 appr\u00e9hender leur rendement personnel et \u00e0 savoir o\u00f9 il se situe par rapport \u00e0 celui de leurs pairs. Gr\u00e2ce \u00e0 des fiches de rendement suivant un ensemble de mesures standard, les radiologistes peuvent cerner les domaines dans lesquels ils doivent s\u2019am\u00e9liorer et les mesures \u00e0 mettre en \u0153uvre pour atteindre leurs objectifs.<\/p>\n<h2>Les fiches de rendement normalis\u00e9es dans la pratique<\/h2>\n<p>Une r\u00e9troaction normalis\u00e9e peut v\u00e9ritablement changer la donne. Un programme provincial canadien de d\u00e9pistage a signal\u00e9 une r\u00e9duction des taux de rappel pour anomalie de 9 % \u00e0 6 %, apr\u00e8s avoir introduit des r\u00e9troactions confidentielles et des fiches de rendement normalis\u00e9es pour les radiologistes.<\/p>\n<p>Il existe de nombreuses fa\u00e7ons de cr\u00e9er et d\u2019utiliser des fiches de rendement normalis\u00e9es. Le Royaume-Uni, par exemple, a recours \u00e0 un syst\u00e8me de rapports de suivi de l\u2019activit\u00e9 des radiologistes \u00e0 base de quadrants, offrant, \u00e0 chacun d\u2019entre eux, des recommandations sur la fa\u00e7on de passer du quadrant o\u00f9 il se trouve au quadrant sup\u00e9rieur.<\/p>\n<p>Au Canada, Sant\u00e9 Ontario et l\u2019Ordre des m\u00e9decins et chirurgiens de l\u2019Ontario ont mis au point un m\u00e9canisme similaire. La Colombie\u2011Britannique et le Qu\u00e9bec utilisent d\u00e9j\u00e0 certains \u00e9l\u00e9ments de ce syst\u00e8me, et plusieurs autres provinces ont recours \u00e0 diverses formes de r\u00e9troaction et de rapports normalis\u00e9s pour mesurer le rendement des radiologistes.<\/p>\n<h2>Mise en \u0153uvre concr\u00e8te<\/h2>\n<p>Les programmes de d\u00e9pistage organis\u00e9 du cancer du sein mettront plus facilement en \u0153uvre cette approche en adoptant les mesures suivantes :<\/p>\n<ol>\n<li>Cr\u00e9ation, pour tous les radiologistes, de fiches de rendement normalis\u00e9es comprenant toujours les m\u00eames statistiques (par exemple le taux de d\u00e9tection de cancers, les valeurs pr\u00e9dictives positives, les faux positifs, le nombre d\u2019interpr\u00e9tations et le taux de rappel pour anomalie);<\/li>\n<li>Attribution \u00e0 chaque radiologiste, en fonction de sa note, d\u2019objectifs personnels \u00e0 court terme et \u00e0 long terme, accompagn\u00e9s de conseils sur la fa\u00e7on de les atteindre;<\/li>\n<li>Organisation d\u2019un suivi obligatoire avec les radiologistes dont le rendement est inf\u00e9rieur au niveau souhait\u00e9, afin de discuter de strat\u00e9gies d\u2019am\u00e9lioration.<\/li>\n<\/ol>\n<h3>Cl\u00e9s du succ\u00e8s<\/h3>\n<ul>\n<li>Donn\u00e9es \u00e0 jour accessibles rapidement<\/li>\n<li>Objectifs et \u00e9ch\u00e9anciers clairs<\/li>\n<li>Comparaisons non ambigu\u00ebs, entre les programmes, entre les provinces, etc., en mati\u00e8re de rendement<\/li>\n<li>Prise en compte des commentaires des radiologistes pour am\u00e9liorer les mod\u00e8les<\/li>\n<\/ul>\n<h3>D\u00e9fis \u00e0 surmonter<\/h3>\n<ul>\n<li>Co\u00fbts<\/li>\n<li>Motivation et participation des radiologistes<\/li>\n<\/ul>\n<h2><strong>Approches suppl\u00e9mentaires pour am\u00e9liorer les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein par mammographie<\/strong><\/h2>\n<p>Apprenez-en davantage sur l\u2019<a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/peer-review-mentorship\/\">examen par les pairs et le mentorat<\/a>, la <a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/education\/\">formation<\/a>, le <a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/minimum-reading-volumes\">nombre minimal d\u2019interpr\u00e9tations<\/a>, l\u2019<a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/batch-reading\/\">interpr\u00e9tation par lots<\/a> et la\u00a0<a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/double-reading\">double interpr\u00e9tation<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les fiches de rendement normalis\u00e9es aident les radiologistes \u00e0 appr\u00e9hender leur rendement personnel et \u00e0 savoir o\u00f9 il se situe par rapport \u00e0 celui de leurs pairs. Gr\u00e2ce \u00e0 des fiches de rendement suivant un ensemble de mesures standard, les radiologistes peuvent cerner les domaines dans lesquels ils doivent s\u2019am\u00e9liorer et les mesures \u00e0 mettre [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":47860,"menu_order":5,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-47876","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Am\u00e9lioration des TRA : fiches de rendement normalis\u00e9es - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Les fiches de rendement normalis\u00e9es aident les radiologistes \u00e0 appr\u00e9hender leur rendement personnel et \u00e0 savoir o\u00f9 il se situe par rapport \u00e0 celui de leurs pairs. Gr\u00e2ce \u00e0 des fiches de rendement suivant un ensemble de mesures standard, les radiologistes peuvent cerner les domaines dans lesquels ils doivent s\u2019am\u00e9liorer et les mesures \u00e0 mettre [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-14T14:35:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-150x150.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/standardized-report-cards\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/standardized-report-cards\\\/\",\"name\":\"Am\u00e9lioration des TRA : fiches de rendement normalis\u00e9es - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/standardized-report-cards\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/standardized-report-cards\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/icon-3-report-cards-FR.png-150x150.png\",\"datePublished\":\"2020-07-31T09:00:40+00:00\",\"dateModified\":\"2020-08-14T14:35:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/standardized-report-cards\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/standardized-report-cards\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/standardized-report-cards\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/icon-3-report-cards-FR.png-150x150.png\",\"contentUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/icon-3-report-cards-FR.png-150x150.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/standardized-report-cards\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cadre pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Am\u00e9lioration des TRA : fiches de rendement normalis\u00e9es\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/","og_locale":"fr_FR","og_type":"article","og_title":"Am\u00e9lioration des TRA : fiches de rendement normalis\u00e9es - Canadian Partnership Against Cancer","og_description":"Les fiches de rendement normalis\u00e9es aident les radiologistes \u00e0 appr\u00e9hender leur rendement personnel et \u00e0 savoir o\u00f9 il se situe par rapport \u00e0 celui de leurs pairs. Gr\u00e2ce \u00e0 des fiches de rendement suivant un ensemble de mesures standard, les radiologistes peuvent cerner les domaines dans lesquels ils doivent s\u2019am\u00e9liorer et les mesures \u00e0 mettre [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2020-08-14T14:35:34+00:00","og_image":[{"url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-150x150.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/","name":"Am\u00e9lioration des TRA : fiches de rendement normalis\u00e9es - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/#primaryimage"},"image":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/#primaryimage"},"thumbnailUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-150x150.png","datePublished":"2020-07-31T09:00:40+00:00","dateModified":"2020-08-14T14:35:34+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/#primaryimage","url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-150x150.png","contentUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/07\/icon-3-report-cards-FR.png-150x150.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/standardized-report-cards\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Cadre pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/"},{"@type":"ListItem","position":3,"name":"Am\u00e9lioration des TRA : fiches de rendement normalis\u00e9es"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/47876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/47860"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=47876"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=47876"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=47876"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=47876"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=47876"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=47876"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=47876"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=47876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}